OMB.report

Federal forms, ICRs, and supporting documents

Information Collection

Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements (Cognitive Interviews)

IC 216972 under ICR 201601-0910-001 · OMB 0910-0695.

Documents and Forms
Document Name
Document Type
Other-Screener
Other-Testing Guide
IC Document
Information Collection (IC) Details

View Information Collection (IC)

Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements (Cognitive Interviews) CDER
 
Unchanged
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Screener FDA DISCLOSURE - COGNITIVE TESTING SCREENER 6-9-2015.docx Yes Yes Fillable Fileable
Other-Testing Guide RISK DISCLOSURE - COGNITIVIE TESTING GUIDE 6-9-2015.docx Yes Yes Fillable Fileable

Health Consumer Health and Safety

 

498 0
   
Individuals or Households
 
   100 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 498 0 0 0 0 498
Annual IC Time Burden (Hours) 32 0 0 0 0 32
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
OMB Justification Memo OMB Justification for generic clearance in Risks in DTC Prescription Drug TV Ads 6-9-2015.docx 06/10/2015
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.